Retrospective analysis of safety in elderly BRAF V600 mutation-positive advanced melanoma patients treated with dabrafenib (D) and trametinib (T) and correlation with non-elderly patients

Garcia-Castano, A.Gonzalez-Barrallo, I.Castellon Rubio, V. E.Medina Martinez, J.Manzano Mozo, J. L.Mujika, K.Majem Tarruella, M.Aguado de La Rosa, C.Cabrera Suarez, M. A.Palacio, I.Osterloh, L.Martinez Fernandez, A.2025-01-072025-01-072020-09-010923-7534https://hdl.handle.net/10668/24898enRetrospective analysis of safety in elderly BRAF V600 mutation-positive advanced melanoma patients treated with dabrafenib (D) and trametinib (T) and correlation with non-elderly patientsconference outputopen access10.1016/j.annonc.2020.08.12411569-8041http://www.annalsofoncology.org/article/S0923753420412372/pdf573469101405